SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Quest Diagnostics to add Roche ptau217, launch Ad-detect test

Quest Diagnostics says it will incorporate Roche ptau217 testing into Ad-detect panels in 2027 and launch a new Ad-detect multi-biomarker lab test nationwide at month-end.

DGXRHHBY

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.